DSM-Firmenich AG (LON:0AC9)

Market Cap	20.82B
Revenue (ttm)	10.58B
Net Income (ttm)	206.74M
Shares Out	n/a
EPS (ttm)	0.78
PE Ratio	100.69
Forward PE	n/a
Dividend	2.15 (2.39%)
Ex-Dividend Date	May 9, 2024

Volume	465,268
Average Volume	233,195
Open	89.60
Previous Close	89.53
Day's Range	89.44 - 90.50
52-Week Range	71.42 - 103.54
Beta	n/a
RSI	55.04
Earnings Date	Jul 31, 2025

About DSM-Firmenich AG

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and s...

• Industry: Chemicals and Allied Products
• Founded: 1902
• Employees: 26,301
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0AC9

Financial Performance

In 2024, DSM-Firmenich AG's revenue was 12.80 billion, an increase of 20.44% compared to the previous year's 10.63 billion. Earnings were 250.00 million, a decrease of -88.27%.

Financial numbers in EUR